$EIKN

$11.21▲ -1.5% YTD

2 SEC 13D/G filings tracked · Last updated Sep 3, 2026

Filing History

CP $11.21▲ -1.5%Sep 3, 2026 · ThinkSabio Blog

$EIKN - Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer…

SEC 13D/G

EIKN - Eikon Therapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$9.08▼ -39.06%Aug 6, 2026 · ThinkSabio Blog

$EIKN SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #EIKN Eikon Therapeutics, Inc. : $9.08 Sector: Healthcare | YTD:…